LUNG Market Cap History
Below is a table of the LUNG market cap history going back to 10/1/2020:

Date LUNG Market Cap
10/1/20201.21B
10/30/20201.50B
3/4/20212.03B
4/30/20211.70B
7/30/20211.46B
10/31/20211.43B
2/23/2022971.75M
4/30/2022894.51M
7/29/2022635.05M
10/28/2022505.02M

Also see: LUNG Shares Outstanding History
and LUNG YTD Return
LUNG Historical Market Cap:
-34.32% CAGR
LUNG Historical Market Cap: +-34.32% CAGR

Mouse over chart for data details
10/1/202010/30/20203/4/20214/30/20217/30/202110/31/20212/23/20224/30/20227/29/202210/28/2022
Pulmonx is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. Co.'s solution, which is comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. Co.'s solution is designed to address the need for for patients with severe emphysema, providing bronchoscopic lung volume reduction without surgery and its associated risks. We show 10 historical shares outstanding datapoints in our LUNG shares outstanding history coverage, used to compute LUNG market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing LUNG market cap history over the course of time is important for investors interested in comparing LUNG's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of LUNG versus a peer is one thing; comparing LUNG market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like LUNG can fluctuate over the course of history. With this page we aim to empower investors researching LUNG by allowing them to research the LUNG market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree LUNG Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Pulmonx (LUNG) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

LVGO Market Cap History
LXRX Market Cap History
LYEL Market Cap History
LYRA Market Cap History
MACK Market Cap History
MASI Market Cap History
MBIO Market Cap History
MBOT Market Cap History
MBRX Market Cap History
MBVX Market Cap History
More Healthcare companies »

 

LUNG Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.